Rezultati - Robyn P.M. Saw
- Showing 1 - 20 results of 44
- Go to Next Page
-
1
Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma od Farhad Azimi, Richard A. Scolyer, Pavlina Rumcheva, Marc Moncrieff, Rajmohan Murali, Stanley W. McCarthy, Robyn P.M. Saw, John F. Thompson
Izdano 2012Artigo -
2
-
3
Negative immune checkpoint regulation by VISTA: a mechanism of acquired resistance to anti-PD-1 therapy in metastatic melanoma patients od Hojabr Kakavand, Louise Jackett, Alexander M. Menzies, Tuba N. Gide, Matteo S. Carlino, Robyn P.M. Saw, John F. Thompson, James S. Wilmott, Georgina V. Long, Richard A. Scolyer
Izdano 2017Artigo -
4
Antiproliferative Effects of Continued Mitogen-Activated Protein Kinase Pathway Inhibition following Acquired Resistance to BRAF and/or MEK Inhibition in Melanoma od Matteo S. Carlino, Kavitha Gowrishankar, Catherine A.B. Saunders, Gulietta M. Pupo, Stephanie Snoyman, Xu Dong Zhang, Robyn P.M. Saw, Therese M. Becker, Richard Kefford, Georgina V. Long, Helen Rizos
Izdano 2013Artigo -
5
-
6
Close proximity of immune and tumor cells underlies response to anti-PD-1 based therapies in metastatic melanoma patients od Tuba N. Gide, Inês Pires da Silva, Camelia Quek, Tasnia Ahmed, Alexander M. Menzies, Matteo S. Carlino, Robyn P.M. Saw, John F. Thompson, Marcel Batten, Georgina V. Long, Richard A. Scolyer, James S. Wilmott
Izdano 2019Artigo -
7
The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma od Su Yin Lim, Elena Shklovskaya, Jenny Lee, Bernadette Pedersen, Ashleigh Stewart, Zizhen Ming, Mal Irvine, Brindha Shivalingam, Robyn P.M. Saw, Alexander M. Menzies, Matteo S. Carlino, Richard A. Scolyer, Georgina V. Long, Helen Rizos
Izdano 2023Artigo -
8
PD-L1 Expression and Immune Escape in Melanoma Resistance to MAPK Inhibitors od Hojabr Kakavand, Robert V. Rawson, Gulietta M. Pupo, Jean Yang, Alexander M. Menzies, Matteo S. Carlino, Richard Kefford, Julie R. Howle, Robyn P.M. Saw, John F. Thompson, James S. Wilmott, Georgina V. Long, Richard A. Scolyer, Helen Rizos
Izdano 2017Artigo -
9
Recurrent hotspot SF3B1 mutations at codon 625 in vulvovaginal mucosal melanoma identified in a study of 27 Australian mucosal melanomas od Camelia Quek, Robert V. Rawson, Peter M. Ferguson, Ping Shang, Inês Pires da Silva, Robyn P.M. Saw, Kerwin F. Shannon, John F. Thompson, Nicholas K. Hayward, Georgina V. Long, Graham J. Mann, Richard A. Scolyer, James S. Wilmott
Izdano 2019Artigo -
10
Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patients od Jenny Lee, Robyn P.M. Saw, John F. Thompson, Serigne Lo, Andrew J. Spillane, Kerwin F. Shannon, Jonathan R. Stretch, Julie R. Howle, Alexander M. Menzies, Matteo S. Carlino, Richard Kefford, Georgina V. Long, Richard A. Scolyer, Helen Rizos
Izdano 2019Artigo -
11
Tumor MHC Expression Guides First-Line Immunotherapy Selection in Melanoma od Elena Shklovskaya, Jenny Lee, Su Yin Lim, Ashleigh Stewart, Bernadette Pedersen, Peter M. Ferguson, Robyn P.M. Saw, John F. Thompson, Brindha Shivalingam, Matteo S. Carlino, Richard A. Scolyer, Alexander M. Menzies, Georgina V. Long, Richard Kefford, Helen Rizos
Izdano 2020Artigo -
12
Neurotropic melanoma: an analysis of the clinicopathological features, management strategies and survival outcomes for 671 patients treated at a tertiary referral center od Alexander H. R. Varey, Chris Goumas, Angela Hong, Graham J. Mann, Gerald B. Fogarty, Jonathan R. Stretch, Robyn P.M. Saw, Andrew J. Spillane, Kerwin F. Shannon, Kenneth J. Lee, Michael J. Quinn, John F. Thompson, Richard A. Scolyer
Izdano 2017Artigo -
13
Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma od Georgina V. Long, Carina Fung, Alexander M. Menzies, Gulietta M. Pupo, Matteo S. Carlino, Jessica Hyman, Hamideh Shahheydari, Varsha Tembe, John F. Thompson, Robyn P.M. Saw, Julie R. Howle, Nicholas K. Hayward, Peter A. Johansson, Richard A. Scolyer, Richard Kefford, Helen Rizos
Izdano 2014Artigo -
14
BRAF Inhibitor Resistance Mechanisms in Metastatic Melanoma: Spectrum and Clinical Impact od Helen Rizos, Alexander M. Menzies, Gulietta M. Pupo, Matteo S. Carlino, Carina Fung, Jessica Hyman, Lauren E. Haydu, Branka Mijatov, Therese M. Becker, Suzanah C. Boyd, Julie R. Howle, Robyn P.M. Saw, John F. Thompson, Richard Kefford, Richard A. Scolyer, Georgina V. Long
Izdano 2014Artigo -
15
Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition od Jenny Lee, Elena Shklovskaya, Su Yin Lim, Matteo S. Carlino, Alexander M. Menzies, Ashleigh Stewart, Bernadette Pedersen, Malama Irvine, Sara Alavi, Jean Yang, Dario Strbenac, Robyn P.M. Saw, John F. Thompson, James S. Wilmott, Richard A. Scolyer, Georgina V. Long, Richard Kefford, Helen Rizos
Izdano 2020Artigo -
16
Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia Nomogram od Serigne Lo, Jiawen Ma, Richard A. Scolyer, Lauren E. Haydu, Jonathan R. Stretch, Robyn P.M. Saw, Omgo E. Nieweg, Kerwin F. Shannon, Andrew J. Spillane, Sydney Ch’ng, Graham J. Mann, Jeffrey E. Gershenwald, John F. Thompson, Alexander H. R. Varey
Izdano 2020Artigo -
17
Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma od Ricardo E. Vilain, Alexander M. Menzies, James S. Wilmott, Hojabr Kakavand, Jason Madore, Alexander Guminski, Elizabeth Liniker, Benjamin Y. Kong, Adam Cooper, Julie R. Howle, Robyn P.M. Saw, Valerie Jakrot, Serigne Lo, John F. Thompson, Matteo S. Carlino, Richard Kefford, Georgina V. Long, Richard A. Scolyer
Izdano 2017Artigo -
18
CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment od Jarem Edwards, James S. Wilmott, Jason Madore, Tuba N. Gide, Camelia Quek, Annie Tasker, Angela L. Ferguson, Jinbiao Chen, Rehana Hewavisenti, Peter Hersey, Thomas Gebhardt, Wolfgang Weninger, Warwick J. Britton, Robyn P.M. Saw, John F. Thompson, Alexander M. Menzies, Georgina V. Long, Richard A. Scolyer, Umaimainthan Palendira
Izdano 2018Artigo -
19
Leg Lymphoedema After Inguinal and Ilio-Inguinal Lymphadenectomy for Melanoma: Results from a Prospective, Randomised Trial od T. S. Lee, Isabel Li, Barbara Perić, Robyn P.M. Saw, João Pedreira Duprat Neto, Eduardo Bertolli, John Spillane, Barbara L. van Leeuwen, Marc Moncrieff, Antonio Sommariva, Chris Allan, Johannes H.W. de Wilt, Rowan O. Pritchard Jones, Jenny L. C. Geh, Julie R. Howle, Andrew J. Spillane
Izdano 2024Artigo -
20
Neoadjuvant pembrolizumab, dabrafenib and trametinib in BRAFV600-mutant resectable melanoma: the randomized phase 2 NeoTrio trial od Georgina V. Long, Matteo S. Carlino, George Au‐Yeung, Andrew J. Spillane, Kerwin F. Shannon, David Gyorki, Edward Hsiao, Rony Kapoor, Jake Thompson, Iris Batula, Julie R. Howle, Sydney Ch’ng, Maria Gonzalez, Robyn P.M. Saw, Thomas E. Pennington, Serigne Lo, Richard A. Scolyer, Alexander M. Menzies
Izdano 2024Artigo
Iskalna orodja:
Sorodne teme
Cancer research
Melanoma
Medicine
Cancer
Biology
Internal medicine
Oncology
Immunotherapy
Breast cancer
Gene
Genetics
Immunology
Immune system
Biochemistry
Pathology
Surgery
Metastatic melanoma
KRAS
Neoadjuvant therapy
Neuroblastoma RAS viral oncogene homolog
Immune checkpoint
Ipilimumab
Mutation
Nivolumab
Paleontology
Stage (stratigraphy)
Biopsy
CD8
Genome
Lymph node